Tuberculosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years of age or older; people of all genders and races are welcome.
- You have been recently diagnosed with active tuberculosis (TB) in the lungs, either through a clinical diagnosis or a procedure called bronchoscopy, within the last week.
- You have a latent (hidden/inactive) TB infection, meaning a specific blood test called T-SPOT came back positive but you do not currently have active TB disease.
- You have TB affecting the lining around your lungs (called tuberculous pleurisy) that was diagnosed within the last week.
- You are willing to take part in this study and able to sign a consent form agreeing to join.
- Your test results show that your TB bacteria are resistant to at least two common TB medicines (isoniazid and rifampicin), which is known as drug-resistant TB (MDR-TB).
- Your test results show that your TB bacteria respond normally to the standard first-line TB medicines.
- Your test results show that your TB bacteria are resistant to only one TB medicine.
- You have been newly diagnosed (within the last week) with a lung infection caused by bacteria related to TB, called nontuberculous mycobacteria (NTM), confirmed through a sputum (mucus) test or genetic testing.
Who may not be able to join:
- You have a weakened immune system, such as HIV infection, have been taking immune-suppressing medicines or steroids for more than one month, or have severe malnutrition.
- You have another serious lung condition, severe liver or kidney problems, a serious hormonal or blood disorder, or cancer that could affect the study results.
- You have diabetes.
- You are pregnant or currently breastfeeding.
- You are unable or unwilling to give your consent to take part, or you may have difficulty following the study requirements.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-0574-87089878
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To establish a multi-immune pathway interaction network and composite biomarkers in mycobacterial infection thing
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.